Advanced
  Home Compare Reports

Comparison with Similar Reports

Airway Management Devices Market by type (Endotracheal tubes, Tracheostomy tube, LMA, Oropharyngeal, Nasopharyngeal, Laryngoscopes, Bougies), Applicat...

Publisher:        MarketsandMarkets

# of Pages:        263

Rating: 

1 User License $4,950

Publication Date:  May, 2021

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS 33
1.2.2 MARKETS COVERED 34
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 35
1.4 LIMITATIONS 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH APPROACH 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY RESEARCH 38
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY RESEARCH 40
2.1.2.1 Primary sources 40
2.1.2.2 Key data from primary sources 41
2.1.2.3 Insights from primary experts 42
2.1.2.4 Breakdown of primary 43
2.2 MARKET SIZE ESTIMATION 43
FIGURE 2 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 3 AIRWAY MANAGEMENT DEVICES MARKET REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 44
FIGURE 4 SEGMENTAL EXTRAPOLATION OF THE LARYNGOSCOPES MARKET 45
FIGURE 5 SEGMENTAL EXTRAPOLATION OF TRACHEOSTOMY TUBES SEGMENT 46
FIGURE 6 CAGR PROJECTIONS 47
FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE AIRWAY MANAGEMENT MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR 47
2.3 DATA TRIANGULATION APPROACH 49
FIGURE 8 DATA TRIANGULATION METHODOLOGY 49
2.4 MARKET SHARE ESTIMATION 50
2.5 ASSUMPTIONS FOR THE STUDY 50
2.6 RISK ASSESSMENT 51
TABLE 2 RISK ASSESSMENT: AIRWAY MANAGEMENT DEVICES MARKET 51
 
3 EXECUTIVE SUMMARY 52
FIGURE 9 AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 52
FIGURE 10 INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 53
FIGURE 11 SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 53
FIGURE 12 LARYNGOSCOPES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 54
FIGURE 13 AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2021 VS. 2026 (USD MILLION) 55
FIGURE 14 AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATIONS,
2021 VS. 2026 (USD MILLION) 56
FIGURE 15 AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 57
FIGURE 16 GEOGRAPHIC ANALYSIS: AIRWAY MANAGEMENT DEVICES MARKET 58
4 PREMIUM INSIGHTS 59
4.1 AIRWAY MANAGEMENT DEVICES MARKET OVERVIEW 59
FIGURE 17 INCREASING CASES OF CHRONIC RESPIRATORY DISEASES AND GROWING DEVELOPMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE GROWTH 59
4.2 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE 60
FIGURE 18 ADULT PATIENTS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICA AIRWAY MANAGEMENT DEVICES MARKET IN 2020 60
4.3 AIRWAY MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 19 INDIA TO REGISTER THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 61
4.4 AIRWAY MANAGEMENT DEVICES MARKET, BY REGION (2019–2026) 62
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE AIRWAY MANAGEMENT DEVICES MARKET DURING THE FORECAST PERIOD 62
4.5 AIRWAY MANAGEMENT DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 63
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
TABLE 3 MARKET DYNAMICS: AIRWAY MANAGEMENT DEVICES MARKET 64
5.2.1 DRIVERS 65
5.2.1.1 Rising prevalence of chronic respiratory diseases 65
TABLE 4 POPULATION AGED 65 YEARS AND OVER, BY REGION (IN MILLION) 65
5.2.1.2 Increasing demand for emergency and intensive care 65
5.2.1.3 Growing incidence of pre-term births 66
FIGURE 22 NUMBER OF PRE-TERM BIRTHS (DEVELOPED, LATIN AMERICAN, AND CARIBBEAN COUNTRIES), 1990–2025 67
5.2.1.4 Government support for improving emergency care infrastructure 67
5.2.2 RESTRAINTS 68
5.2.2.1 Lack of reimbursement policies across developing countries 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Growing demand for single-use airway management devices 68
5.2.3.2 Growth potential in emerging countries 69
TABLE 5 COMPARISON OF SURGERY COSTS: INDIA VS. US 69
5.2.4 CHALLENGES 70
5.2.4.1 Harmful effects of certain devices on neonates 70
5.2.4.2 Dearth of skilled professionals 70
5.2.4.3 Increasing pricing pressure on market players 71
6 INDUSTRY INSIGHTS 72
6.1 INTRODUCTION 72
6.2 INDUSTRY TRENDS 72
6.2.1 USE OF ECO-FRIENDLY AND BIODEGRADABLE POLYMERS IN AIRWAY MANAGEMENT DEVICE MANUFACTURING 72
6.3 DEMAND-SIDE ANALYSIS 73
6.3.1 GROWING ADOPTION OF ADVANCED INTUBATION TUBE HOLDERS 73
6.4 REGULATORY ANALYSIS 73
6.4.1 NORTH AMERICA 73
6.4.1.1 US 73
TABLE 6 US: FDA CLASSIFICATION OF AIRWAYS MANAGEMENT DEVICES 73
TABLE 7 US: REGULATORY PROCESS FOR MEDICAL DEVICES 74
6.4.1.2 Canada 74
6.4.2 EUROPE 74
6.4.3 ASIA PACIFIC 75
6.4.3.1 Japan 75
TABLE 8 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 75
6.4.3.2 China 75
TABLE 9 NMPA MEDICAL DEVICE CLASSIFICATION 76
6.4.3.3 India 76
6.5 PORTER’S FIVE FORCES ANALYSIS 77
TABLE 10 PORTER’S FIVE FORCES ANALYSIS 77
6.5.1 THREAT OF NEW ENTRANTS 77
6.5.2 THREAT OF SUBSTITUTES 77
6.5.3 BARGAINING POWER OF SUPPLIERS 77
6.5.4 BARGAINING POWER OF BUYERS 78
6.5.5 INTENSITY OF COMPETITIVE RIVALRY 78
6.6 VALUE CHAIN ANALYSIS 78
FIGURE 23 VALUE CHAIN: AIRWAYS MANAGEMENT DEVICES MARKET 78
6.7 COVID-19 IMPACT ON THE AIRWAY MANAGEMENT DEVICES MARKET 79
6.8 ECOSYSTEM ANALYSIS 80
FIGURE 24 AIRWAY MANAGEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS 80
6.9 PATENT ANALYSIS 80
FIGURE 25 TOTAL PATENTS PUBLISHED FOR AIRWAY MANAGEMENT DEVICES FROM 2015–2021 80
FIGURE 26 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR AIRWAY MANAGEMENT DEVICES 81
FIGURE 27 TOP INVENTORS FOR AIRWAY MANAGEMENT DEVICES 81
7 AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE 82
7.1 INTRODUCTION 83
TABLE 11 AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
7.2 INFRAGLOTTIC AIRWAY DEVICES 83
TABLE 12 INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 84
TABLE 13 INFRAGLOTTIC AIRWAY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 14 INFRAGLOTTIC AIRWAY MANAGEMENT DEVICES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 85
7.2.1 ENDOTRACHEAL TUBES 85
7.2.1.1 ETTs are regarded as the gold standard for airway management 85
TABLE 15 ENDOTRACHEAL TUBES OFFERED BY KEY MARKET PLAYERS 86
TABLE 16 ENDOTRACHEAL TUBES MARKET, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 17 ENDOTRACHEAL TUBES MARKET, BY REGION, 2019–2026 (MILLION UNITS) 87
7.2.2 TRACHEOSTOMY TUBES 87
7.2.2.1 Tracheostomy is the most commonly performed procedure in ICUs, which ensures high adoption of tubes 87
TABLE 18 TRACHEOSTOMY TUBES OFFERED BY KEY MARKET PLAYERS 88
TABLE 19 TRACHEOSTOMY TUBES MARKET, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 20 TRACHEOSTOMY TUBES MARKET, BY REGION, 2019–2026 (MILLION UNITS) 89
7.3 SUPRAGLOTTIC AIRWAY DEVICES 89
TABLE 21 SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 90
TABLE 22 SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
TABLE 23 SUPRAGLOTTIC AIRWAY MANAGEMENT DEVICES MARKET, BY REGION, 2019–2026 (MILLION UNITS) 91
7.3.1 LARYNGEAL MASK AIRWAY DEVICES 91
7.3.1.1 LMAs hold the largest share of the supraglottic airway devices market 91
TABLE 24 LARYNGEAL MASK AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS 92
TABLE 25 LARYNGEAL MASK AIRWAY DEVICES MARKET, BY COUNTRY ,
2019–2026 (USD MILLION) 93
TABLE 26 LARYNGEAL MASK AIRWAY DEVICES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 93
7.3.2 OROPHARYNGEAL AIRWAY DEVICES 94
7.3.2.1 OPAs are used in unconscious or unresponsive patients 94
TABLE 27 OROPHARYNGEAL AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS 94
TABLE 28 OROPHARYNGEAL AIRWAY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 29 OROPHARYNGEAL AIRWAY DEVICES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 95
7.3.3 NASOPHARYNGEAL AIRWAY DEVICES 96
7.3.3.1 NPAs are preferred as they do not stimulate the gag reflex 96
TABLE 30 NASOPHARYNGEAL AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS 96
TABLE 31 NASOPHARYNGEAL AIRWAY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 32 NASOPHARYNGEAL AIRWAY DEVICES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 97
7.3.4 OTHER SUPRAGLOTTIC AIRWAY DEVICES 98
TABLE 33 OTHER SUPRAGLOTTIC AIRWAY DEVICES OFFERED BY KEY MARKET PLAYERS 98
TABLE 34 OTHER SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 99
TABLE 35 OTHER SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 99
7.4 LARYNGOSCOPES 100
TABLE 36 LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 100
TABLE 37 LARYNGOSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 38 LARYNGOSCOPES MARKET, BY REGION, 2019–2026 (MILLION UNITS) 101
7.4.1 CONVENTIONAL LARYNGOSCOPES 102
7.4.1.1 Low prices and long history of use have ensured the dominance of conventional laryngoscopes in the market 102
TABLE 39 CONVENTIONAL LARYNGOSCOPES OFFERED BY KEY MARKET PLAYERS 102
TABLE 40 CONVENTIONAL LARYNGOSCOPES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 103
TABLE 41 CONVENTIONAL LARYNGOSCOPES MARKET, BY REGION,
2019–2026 (MILLION UNITS) 103
7.4.2 VIDEO LARYNGOSCOPES 104
7.4.2.1 High prices of video laryngoscopes restrict access 104
TABLE 42 VIDEO LARYNGOSCOPES OFFERED BY KEY MARKET PLAYERS 104
TABLE 43 VIDEO LARYNGOSCOPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 44 VIDEO LARYNGOSCOPES MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 105
7.5 RESUSCITATORS 106
7.5.1 RESUSCITATORS ARE PREFERRED IN PEDIATRIC PATIENTS/NEONATES 106
TABLE 45 RESUSCITATORS OFFERED BY KEY MARKET PLAYERS 106
TABLE 46 RESUSCITATORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 47 RESUSCITATORS MARKET, BY REGION, 2019–2026 (MILLION UNITS) 107
7.6 CRICOTHYROTOMY KITS 108
7.6.1 RISING NUMBER OF TRAFFIC ACCIDENTS AND RELATED HEAD AND NECK INJURIES DRIVES MARKET GROWTH 108
TABLE 48 CRICOTHYROTOMY KITS OFFERED BY KEY MARKET PLAYERS 108
TABLE 49 CRICOTHYROTOMY KITS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 50 CRICOTHYROTOMY KITS MARKET, BY REGION,
2019–2026 (THOUSAND UNITS) 109
7.7 OTHER AIRWAY MANAGEMENT DEVICES 110
TABLE 51 OTHER AIRWAY MANAGEMENT DEVICES OFFERED BY KEY MARKET PLAYERS 110
TABLE 52 OTHER AIRWAY MANAGEMENT DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 111
8 AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE 112
8.1 INTRODUCTION 113
TABLE 53 AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 113
8.2 ADULT PATIENTS 113
8.2.1 ADULTS HOLD LARGEST SHARE OF THE MARKET IN TERMS OF AGE GROUP 113
TABLE 54 AIRWAY MANAGEMENT DEVICES MARKET FOR ADULT PATIENTS,
BY COUNTRY, 2019–2026 (USD MILLION) 114
8.3 PEDIATRIC PATIENTS/NEONATES 114
8.3.1 AGE-RELATED DIFFERENCES IN ANATOMY AND PHYSIOLOGY MAKE AIRWAY MANAGEMENT DIFFICULT IN PEDIATRIC PATIENTS & NEONATES 114
FIGURE 28 TOP COUNTRIES WITH THE HIGHEST RATE OF PRE-TERM BIRTHS (2018) 115
TABLE 55 AIRWAY MANAGEMENT DEVICES MARKET FOR PEDIATRIC PATIENTS/NEONATES, BY COUNTRY, 2019–2026 (USD MILLION) 116
9 AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION 117
9.1 INTRODUCTION 118
TABLE 56 AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 118
9.2 ANESTHESIA 118
9.2.1 ANESTHESIA HOLDS THE LARGEST SHARE OF THE APPLICATIONS MARKET 118
TABLE 57 AIRWAY MANAGEMENT DEVICES MARKET FOR ANESTHESIA, BY COUNTRY, 2019–2026 (USD MILLION) 119
9.3 EMERGENCY MEDICINE 119
9.3.1 RESUSCITATORS AND SUPRAGLOTTIC AIRWAY MANAGEMENT DEVICES ARE WIDELY USED IN INITIAL PHASES OF EMERGENCY CARE 119
TABLE 58 AIRWAY MANAGEMENT DEVICES MARKET FOR EMERGENCY MEDICINE,
BY COUNTRY, 2019–2026 (USD MILLION) 120
9.4 OTHER APPLICATIONS 120
TABLE 59 AIRWAY MANAGEMENT DEVICES MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2019–2026 (USD MILLION) 121
 
10 AIRWAY MANAGEMENT DEVICES MARKET, BY END USER 122
10.1 INTRODUCTION 123
TABLE 60 AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 123
10.2 HOSPITALS 123
TABLE 61 AIRWAY MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY DEPARTMENT, 2019–2026 (USD MILLION) 124
TABLE 62 AIRWAY MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2019–2026 (USD MILLION) 125
10.2.1 OPERATING ROOMS 125
10.2.1.1 Rising surgical volume drives demand for airway management devices in the OR 125
TABLE 63 US: INCREASE IN THE NUMBER OF SURGICAL PROCEDURES PERFORMED 126
TABLE 64 AIRWAY MANAGEMENT DEVICES MARKET FOR OPERATING ROOMS,
BY COUNTRY, 2019–2026 (USD MILLION) 126
10.2.2 EMERGENCY CARE DEPARTMENTS 127
10.2.2.1 The rising number of emergencies and trauma care patients drive market growth 127
TABLE 65 AIRWAY MANAGEMENT DEVICES MARKET FOR EMERGENCY CARE DEPARTMENTS, BY COUNTRY, 2019–2026 (USD MILLION) 127
10.2.3 INTENSIVE CARE UNITS 128
10.2.3.1 Rising disease prevalence and the need for monitoring are key growth drivers 128
TABLE 66 AIRWAY MANAGEMENT DEVICES MARKET FOR INTENSIVE CARE UNITS,
BY COUNTRY, 2019–2026 (USD MILLION) 128
10.3 AMBULATORY CARE SETTINGS 129
10.3.1 COST PRESSURE IN THE HOSPITALS SECTOR HAS DRIVEN FOCUS TO AMBULATORY CARE 129
FIGURE 29 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 129
TABLE 67 AIRWAY MANAGEMENT DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2019–2026 (USD MILLION) 130
10.4 HOME CARE SETTINGS 130
10.4.1 RISING AWARENESS AND ACCEPTANCE OF HOME CARE DRIVE MARKET GROWTH 130
TABLE 68 AIRWAY MANAGEMENT DEVICES MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2019–2026 (USD MILLION) 131
10.5 OTHER END USERS 131
TABLE 69 AIRWAY MANAGEMENT DEVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2019–2026 (USD MILLION) 132
11 AIRWAY MANAGEMENT DEVICES MARKET, BY REGION 133
11.1 INTRODUCTION 134
FIGURE 30 AIRWAY MANAGEMENT DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2020) 134
TABLE 70 AIRWAY MANAGEMENT MARKET, BY REGION, 2019–2026 (USD MILLION) 135
11.2 NORTH AMERICA 135
FIGURE 31 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET SNAPSHOT 136
TABLE 71 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 72 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 73 NORTH AMERICA: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 137
TABLE 74 ORTH AMERICA: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 75 NORTH AMERICA: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 138
TABLE 76 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 138
TABLE 77 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 139
TABLE 78 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 139
TABLE 79 NORTH AMERICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY DEPARTMENT, 2019–2026 (USD MILLION) 139
11.2.1 US 140
11.2.1.1 The US dominates the North American airway management devices market 140
TABLE 80 US: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 81 US: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 82 US: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 141
TABLE 83 US: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 142
TABLE 84 US: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 142
TABLE 85 US: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 142
TABLE 86 US: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 143
TABLE 87 US: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 143
11.2.2 CANADA 143
11.2.2.1 Growing government focus on local manufacturing of medical devices 143
TABLE 88 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 144
TABLE 89 CANADA: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 90 CANADA: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 91 CANADA: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 92 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 146
TABLE 93 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 146
TABLE 94 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 146
TABLE 95 CANADA: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT, 2019–2026 (USD MILLION) 147
11.3 EUROPE 147
FIGURE 32 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET SNAPSHOT 148
TABLE 96 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 149
TABLE 97 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 149
TABLE 98 EUROPE: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 99 EUROPE: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 150
TABLE 100 EUROPE: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 150
TABLE 101 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 151
TABLE 102 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 151
TABLE 103 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 151
TABLE 104 EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENTS, 2019–2026 (USD MILLION) 152
11.3.1 GERMANY 152
11.3.1.1 Germany dominated the airway management devices in Europe in 2020 152
TABLE 105 GERMANY: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 106 GERMANY: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 153
TABLE 107 GERMANY: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 154
TABLE 108 GERMANY: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 109 GERMANY: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 154
TABLE 110 GERMANY: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 155
TABLE 111 GERMANY: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 155
TABLE 112 GERMANY: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT, 2019–2026 (USD MILLION) 155
11.3.2 FRANCE 156
11.3.2.1 The presence of an advanced and well-established healthcare system drives the market growth in the country 156
TABLE 113 FRANCE: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 156
TABLE 114 FRANCE: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 115 FRANCE: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 157
TABLE 116 FRANCE: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 117 FRANCE: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 158
TABLE 118 FRANCE: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 158
TABLE 119 FRANCE: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 158
TABLE 120 FRANCE: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 159
11.3.3 UK 159
11.3.3.1 The high prevalence of respiratory disorders is driving the demand for airway management devices in healthcare settings 159
TABLE 121 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 122 UK: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 123 UK: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 160
TABLE 124 UK: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 161
TABLE 125 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 161
TABLE 126 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 161
TABLE 127 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 162
TABLE 128 UK: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 162
11.3.4 ITALY 162
11.3.4.1 Rising surgical volumes drive demand for general anesthesia and airway management in Italy 162
TABLE 129 ITALY: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 130 ITALY: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 131 ITALY: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 164
TABLE 132 ITALY: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 133 ITALY: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 165
TABLE 134 ITALY: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 165
TABLE 135 ITALY: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 165
TABLE 136 ITALY: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 166
11.3.5 SPAIN 166
11.3.5.1 Aging population and the increasing prevalence of respiratory diseases are the key factors driving market growth in Spain 166
TABLE 137 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 138 SPAIN: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 139 SPAIN: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 167
TABLE 140 SPAIN: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 141 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 168
TABLE 142 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 168
TABLE 143 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 169
TABLE 144 SPAIN: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 169
11.3.6 REST OF EUROPE 169
TABLE 145 REST OF EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 146 REST OF EUROPE: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 147 REST OF EUROPE: SUPRAGLOTTIC AIRWAY DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 148 REST OF EUROPE: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 171
TABLE 149 REST OF EUROPE: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 171
TABLE 150 REST OF EUROPE: AIRWAY MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 172
TABLE 151 REST OF EUROPE: AIRWAY MANAGEMENT DEVICES MARKET,
BY END USER, 2019–2026 (USD MILLION) 172
TABLE 152 REST OF EUROPE: AIRWAY MANAGEMENT DEVICES MARKET,
BY DEPARTMENT, 2019–2026 (USD MILLION) 172
11.4 ASIA PACIFIC 173
FIGURE 33 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET SNAPSHOT 174
TABLE 153 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 175
TABLE 154 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 155 ASIA PACIFIC: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 156 ASIA PACIFIC: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 157 ASIA PACIFIC: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 158 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 177
TABLE 159 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 177
TABLE 160 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 177
TABLE 161 ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT, 2019–2026 (USD MILLION) 178
11.4.1 JAPAN 178
11.4.1.1 A strong healthcare system and favorable reimbursement policies support the market growth in Japan 178
TABLE 162 JAPAN: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 163 JAPAN: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 164 JAPAN: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 179
TABLE 165 JAPAN: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 166 JAPAN: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 180
TABLE 167 JAPAN: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 180
TABLE 168 JAPAN: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 181
TABLE 169 JAPAN: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 181
11.4.2 CHINA 181
11.4.2.1 Growth in the number of healthcare facilities and healthcare policy reforms to stimulate market growth in China 181
TABLE 170 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 171 CHINA: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 172 CHINA: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 173 CHINA: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 174 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 183
TABLE 175 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 184
TABLE 176 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 184
TABLE 177 CHINA: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 184
11.4.3 INDIA 185
11.4.3.1 Increasing prevalence of respiratory diseases and pre-term births to drive the demand for airway management devices in India 185
TABLE 178 INDIA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 179 INDIA: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 180 INDIA: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 186
TABLE 181 INDIA: LARYNGOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 187
TABLE 182 INDIA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE,
2019–2026 (USD MILLION) 187
TABLE 183 INDIA: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 187
TABLE 184 INDIA: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 188
TABLE 185 INDIA: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT,
2019–2026 (USD MILLION) 188
11.4.4 REST OF ASIA PACIFIC 188
TABLE 186 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 187 REST OF ASIA PACIFIC: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 188 REST OF ASIA PACIFIC: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 189 REST OF ASIA PACIFIC: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 190 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 190
TABLE 191 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 191
TABLE 192 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET,
BY END USER, 2019–2026 (USD MILLION) 191
TABLE 193 REST OF ASIA PACIFIC: AIRWAY MANAGEMENT DEVICES MARKET,
BY DEPARTMENT, 2019–2026 (USD MILLION) 191
11.5 LATIN AMERICA 192
11.5.1 FAVORABLE REIMBURSEMENT SCENARIO AND HEALTHCARE DEVELOPMENT INITIATIVES TO DRIVE MARKET GROWTH 192
TABLE 194 LATIN AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 195 LATIN AMERICA: INFRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 196 LATIN AMERICA: SUPRAGLOTTIC AIRWAY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 197 LATIN AMERICA: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 198 LATIN AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE, 2019–2026 (USD MILLION) 194
TABLE 199 LATIN AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 194
TABLE 200 LATIN AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 195
TABLE 201 LATIN AMERICA: AIRWAY MANAGEMENT DEVICES MARKET, BY DEPARTMENT, 2019–2026 (USD MILLION) 195
 
11.6 MIDDLE EAST AND AFRICA 195
11.6.1 MEA REPRESENTS THE SMALLEST SEGMENT OF THE AIRWAY MANAGEMENT DEVICES MARKET 195
TABLE 202 MIDDLE EAST AND AFRICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 203 MIDDLE EAST AND AFRICA: INFRAGLOTTIC AIRWAY DEVICES MARKET,
BY TYPE, 2019–2024 (USD MILLION) 197
TABLE 204 MIDDLE EAST AND AFRICA: SUPRAGLOTTIC AIRWAY DEVICES MARKET,
BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 205 MIDDLE EAST AND AFRICA: LARYNGOSCOPES MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 206 MIDDLE EAST AND AFRICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY PATIENT AGE, 2019–2026 (USD MILLION) 198
TABLE 207 MIDDLE EAST AND AFRICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 198
TABLE 208 MIDDLE EAST AND AFRICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY END USER, 2019–2026 (USD MILLION) 198
TABLE 209 MIDDLE EAST AND AFRICA: AIRWAY MANAGEMENT DEVICES MARKET,
BY DEPARTMENT, 2019–2026 (USD MILLION) 199
12 COMPETITIVE LANDSCAPE 200
12.1 OVERVIEW 200
12.2 KEY PLAYER STRATEGIES 200
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 201
FIGURE 34 REVENUE ANALYSIS OF TOP PLAYERS IN THE AIRWAY MANAGEMENT DEVICES MARKET 201
12.4 MARKET SHARE ANALYSIS 202
FIGURE 35 AIRWAY MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020 202
12.5 COMPANY PRODUCT FOOTPRINT 203
12.6 COMPANY END USER FOOTPRINT 204
12.7 COMPANY REGION FOOTPRINT 205
12.8 COMPANY EVALUATION QUADRANT 206
12.8.1 STARS 206
12.8.2 EMERGING LEADERS 206
12.8.3 PERVASIVE PLAYERS 206
12.8.4 PARTICIPANTS 206
FIGURE 36 AIRWAY MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020) 207
12.9 COMPANY EVALUATION QUADRANT: START-UPS 207
12.9.1 PROGRESSIVE COMPANIES 207
12.9.2 DYNAMIC COMPANIES 208
12.9.3 STARTING BLOCKS 208
12.9.4 RESPONSIVE COMPANIES 208
FIGURE 37 AIRWAY MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 208
 
12.10 COMPETITIVE SCENARIO 209
12.10.1 PRODUCT LAUNCHES & APPROVALS 209
TABLE 210 KEY PRODUCT LAUNCHES & APPROVALS, 2018–2021 209
12.10.2 DEALS 210
TABLE 211 KEY DEALS, 2018–2021 210
12.10.3 OTHER DEVELOPMENTS 211
TABLE 212 OTHER DEVELOPMENTS, 2018–2021 211
13 COMPANY PROFILES 212
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 KEY PLAYERS 212
13.1.1 MEDTRONIC 212
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 213
13.1.2 SMITHS MEDICAL (SMITHS GROUP PLC) 217
FIGURE 39 SMITHS MEDICAL: COMPANY SNAPSHOT (2020) 218
13.1.3 TELEFLEX INC. 224
FIGURE 40 TELEFLEX, INC.: COMPANY SNAPSHOT (2020) 224
13.1.4 AMBU A/S 229
FIGURE 41 AMBU A/S: COMPANY SNAPSHOT (2020) 229
13.1.5 CONVATEC GROUP 232
FIGURE 42 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2020) 232
13.1.6 KARL STORZ SE & CO. KG 235
13.1.7 FLEXICARE 237
13.1.8 INTERSURGICAL 239
13.1.9 SUNMED 241
13.1.10 VYAIRE MEDICAL 248
13.1.11 VBM MEDIZINTECHNIK 250
13.1.12 VERATHON 252
FIGURE 43 ROPER TECHNOLOGIES: COMPANY SNAPSHOT (2018) 252
13.1.13 SOURCEMARK LLC 254
13.1.14 MERCURY ENTERPRISES 256
TABLE 213 MERCURY ENTERPRISES: BUSINESS OVERVIEW 256
13.1.15 TRACOE MEDICAL GMBH 258
13.2 OTHER PLAYERS 259
13.2.1 OLYMPUS CORPORATION 259
13.2.2 ARMSTRONG MEDICAL (EAKIN HEALTHCARE GROUP) 259
13.2.3 NIHON KOHDEN CORPORATION 261
13.2.4 SHENZHEN HUGEMED MEDICAL TECHNICAL DEVELOPMENT CO. LTD. 261
13.2.5 VENNER MEDICAL INTERNATIONAL 262
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 263
14.1 DISCUSSION GUIDE 263
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 268
14.3 AVAILABLE CUSTOMIZATIONS 270
14.4 RELATED REPORTS 270
14.5 AUTHOR DETAILS 271

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127